Conclusion: The metabolic pathways of glycolysis, citric acid cycle, and amino acid metabolism were enriched ... A SeQuant ZIC-pHILIC (2.1 × 100 mm, 5-μm particle) column (Merck KGaA, Darmstadt, ...

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...

It's been a rough start to 2025 for Merck (NYSE: MRK) shareholders following a less-than-stellar fourth-quarter earnings report. Even as the pharmaceutical giant exceeded Wall Street estimates ...

Lawsuits surrounding Merck's HPV vaccine Gardasil have been piling up for years now, but they've garnered increased public attention lately after HHS Secretary Robert F. Kennedy Jr.'s links to the ...

Merck & Co.’s first trial over the safety of its blockbuster Gardasil cancer vaccine was cut short and rescheduled amid concerns that jurors might be influenced by controversy this month around ...

Deutsche Bank analyst James Shin downgraded Merck (MRK) to Hold from Buy with a price target of $105, down from $128. The firm believes the “real culprit” for Merck shares remaining under ...

“In our laboratory tests, we found that acidifying milk to a pH of 4.1 to 4.2 with citric acid effectively deactivates the virus.” The UC Davis research team will next conduct on-farm testing of milk ...

Institute of Pharmacy, Pharmaceutical Technology, University of Innsbruck, 6020 Innsbruck, Austria Christian Doppler Laboratory for Advanced Crystal Engineering Strategies in Drug Development, ...

And just to be clear, Merck is a company I like, which, I believe, has amazing fundamentals. You don't need me to make the bull case for Merck: 9 of the last 10 articles on Seeking Alpha have a ...

Courtney Breen, senior analyst of U.S. biopharmaceuticals at Bernstein, discusses Merck's slump in the market following its halt of Gardasil and HPV vaccine shipments in China. February 04, 2025 at ...